Stockhub

Redx Pharma Plc: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

20 September 2022

  • curprev 16:5116:51, 20 September 2022‎ Nick talk contribs‎ 1,218 bytes +1,218‎ Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Redx Pharma Plc engages in drug discovery, pre-clinical development, and licensing activities in the United Kingdom. It discovers and develops small molecule drugs for treating anti-cancer and fibrosis targets in the areas of unmet medical needs. The company also develops RXC004, a porcupine inhibitor that is in Phase II clinical trial for targeted therapy of Wnt-ligand driven cancer; and RXC007, an oral selective rho assoc..." Tag: Visual edit: Switched
Retrieved from ‘https://stockhub.co/research/Redx_Pharma_Plc’